Simeprevir (Hepatitis C Virus)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
2.3 Upcoming Related Reports 9
3 Disease Overview 10
3.1 Etiology and Pathophysiology 10
3.1.1 Etiology 10
3.1.2 Pathophysiology 14
3.1.3 Prognosis 15
3.2 Symptoms 15
4 Disease Management 16
4.1 Diagnosis and Referral Overview 16
4.2 Treatment Overview 17
5 Competitive Assessment 20
5.1 Overview 20
5.2 Strategic Competitor Assessment 20
6 Opportunity and Unmet Need 22
6.1 Overview 22
6.2 Unmet Needs 23
6.2.1 Unmet Need: Treatment Tolerability 23
6.2.2 Unmet Need: Efficacy 23
6.2.3 Unmet Need: Disease Awareness 24
6.2.4 Unmet Need: Treatment Cost 25
6.2.5 Unmet Need: Shorter Treatment Duration 25
6.2.6 Unmet Need: Simplified Treatment Regimens 26
6.3 Unmet Needs Gap Analysis 26
6.4 Opportunities 27
6.4.1 Opportunity: Pan-genotypic HCV Regimen 27
6.4.2 Opportunity: Treatment of Underrepresented Patient Populations 27
6.4.3 Opportunity: Involvement of Immune System 28
7 Pipeline Assessment 29
7.1 Overview 29
7.2 Promising Drugs in Clinical Development 30
8 Simeprevir 32
8.1 Overview 32
8.2 Efficacy 34
8.3 Safety 35
8.4 Dosing and Formulation 36
8.5 Potential Clinical Positioning 36
8.6 Potential Commercial Positioning 37
8.7 Pricing and Reimbursement 37
8.8 SWOT Analysis 38
8.9 Forecast 39
9 Appendix 41
9.1 Bibliography 41
9.2 Abbreviations 43
9.3 Methodology 44
9.4 Forecasting Methodology 44
9.4.1 Percent Drug-Treated Patients 44
9.4.2 Patient Warehousing 45
9.4.3 General Pricing Assumptions 45
9.4.4 Generic Erosion 46
9.4.5 Pricing of Pipeline Agents 46
9.5 Physicians and Specialists Included in this Study 47
9.6 Survey of Prescribing Physicians 49
9.7 About the Authors 50
9.7.1 Author 50
9.7.2 Global Head of Healthcare 50
9.8 About GlobalData 51
9.9 Contact Us 51
9.10 Disclaimer 51